Harrow Health Inc. 8.625% Senior Notes due 2026
Harrow Health Inc. 8.625% Senior Notes due 2026 operates in various business sectors.
Market Cap & Net Worth: Harrow Health Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow Health Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) has a market capitalization of $255.00K ($255.00K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #38972 globally and #12667 in its home market, demonstrating a 0.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Harrow Health Inc. 8.625% Senior Notes due 2026's stock price $25.61 by its total outstanding shares 9957 (9.96K).
Harrow Health Inc. 8.625% Senior Notes due 2026 Market Cap History: 2024 to 2025
Harrow Health Inc. 8.625% Senior Notes due 2026's market capitalization history from 2024 to 2025. Data shows growth from $251.69K to $255.00K (0.00% CAGR).
Harrow Health Inc. 8.625% Senior Notes due 2026 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Harrow Health Inc. 8.625% Senior Notes due 2026's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HROWL by Market Capitalization
Companies near Harrow Health Inc. 8.625% Senior Notes due 2026 in the global market cap rankings as of March 19, 2026.
Key companies related to Harrow Health Inc. 8.625% Senior Notes due 2026 by market ranking:
- Ardiden Limited (PINK:ARDDF): Ranked #38963 globally with a market cap of $244.51K USD.
- NYDSV (OTCGREY:NYDSV): Ranked #38964 globally with a market cap of $244.43K USD.
- CIE DES ALPES (CDA) (F:JCA): Ranked #38973 globally with a market cap of $243.78K USD ( €237.49K EUR).
- TOCT (BATS:TOCT): Ranked #38974 globally with a market cap of $243.61K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #38963 | Ardiden Limited | PINK:ARDDF | $244.51K | $0.01 |
| #38964 | NYDSV | OTCGREY:NYDSV | $244.43K | $25.00 |
| #38973 | CIE DES ALPES (CDA) | F:JCA | $243.78K | €26.15 |
| #38974 | TOCT | BATS:TOCT | $243.61K | $26.46 |
Harrow Health Inc. 8.625% Senior Notes due 2026 Historical Marketcap From 2024 to 2025
Between 2024 and today, Harrow Health Inc. 8.625% Senior Notes due 2026's market cap moved from $251.69K to $ 255.00K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $255.00K | +1.32% |
| 2024 | $251.69K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Harrow Health Inc. 8.625% Senior Notes due 2026 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $255.00K USD |
| MoneyControl | $255.00K USD |
| MarketWatch | $255.00K USD |
| marketcap.company | $255.00K USD |
| Reuters | $255.00K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.